Skip to main content

Table 1 Demographic and clinical characteristics of patients according to asthma control; HUGG, 2013-2014

From: Central obesity and other factors associated with uncontrolled asthma in women

 

ACT

ACT

 

ACQ

ACQ

 

GINA

GINA

 
 

Controlled

Partially/uncontrolled

p value

Controlled

Partially uncontrolled

p value

Controlled

Partially/uncontrolled

p value

Number(%)

71(57.26)

53(42.74)

 

47(37.90)

77(62.10)

 

26(20.97)

98(79.03)

 

Age in years(SD)

53.56(14.61)

53.53(13.28)

0.85

51.40(16.31)

54.86(12.31)

0.21

48.31(16.27)

54.94(13.07)

0.06

BMI(SD)

27.69(4.64)

28.43(4.77)

0.39

27.55(4.49)

28.29(4.81)

0.39

26.77(5.02)

28.33(4.57)

0.16

Obesity(BMI)

        

0.06

Eutrophic(%)

20(28.1)

15(28.4)

0.17

15(32.0)

20(26.0)

0.70

12(46.16)

23(23.47)

Overweight(%)

33(46.5)

17(32.0)

 

19(10.4)

31(40.2)

 

7(26.92)

43(43.88)

Obese(%)

18(25.4)

21(39.6)

 

13(27.6)

26(33.8)

7(26.92)

32(32.65)

Central Obesity(WC)

        

0.0086

Without obesity(%)

25(35.2)

14(26.4)

0.33

21(44.5)

18(23.4)

0.01

14(53.85)

25(25.51)

With obesity(%)

46(64.8)

39(73.6)

 

26(55.5)

59(76.6)

 

12(46.15)

73(74.49)

Central Obesity(WHtR)

        

0.36

Without obesity(%)

6(8.5)

2(3.8)

0.46

4(8.5)

4(5.0)

0.47

3(11.54)

5(5.11)

With obesity(%)

65(91.5)

51(96.2)

 

43(91.5)

73(95.0)

 

23(88.46)

93(94.89)

Central Obesity(CI)

  

0.09

  

0.00

  

0.0015

Without obesity(%)

15(21.1)

5(9.5)

 

14(29.8)

6(8.0)

 

10(38.46)

10(10.20)

With obesity(%)

56(78.9)

48(90.5)

 

33(70.2)

71(92.0)

 

16(61.54)

88(89.80)

Education Level

  

0.05

  

0.33

  

1.0

Less than 4 years(%)

31(43.6)

14(26.5)

 

20(42.5)

25(32.5)

 

9(34.62)

36(36.73)

More than 4 years(%)

40(56.4)

39(73.5)

 

27(57.5)

52(67.5)

 

17(65.38)

62(63.27)

Disease duration in years(SD)

26.08(17.13)

27.43(17.44)

0.66

25.13(16.68)

27(17.56)

0.43

21.61(15.44)

28(17.47)

0.07

Disease duration

  

0.69

  

0.64

  

0.06

Less than 15 years(%)

23(32.4)

15(28.3)

 

15(32.0)

23(29.9)

 

12(46.15)

26(26.53)

More than 15 years(%)

48(67.6)

38(71.7)

 

32(68.0)

54(70.1)

 

14(53.85)

72(73.47)

Age of onset

  

0.67

  

0.52

  

1.0

≤12years(%)

17(24.0)

15(28.3)

 

14(29.8)

18(23.4)

 

7(26.92)

25(25.51)

>12 years(%)

54(76.0)

38(71.7)

 

33(70.2)

59(76.6)

 

19(73.08)

73(74.49)

Asthma after menopause

  

0.65

  

0.64

  

0.59

Yes(%)

13(18.3)

12(22.6)

 

8(17.0)

17(22.0)

 

4(15.38)

21(21.43)

No(%)

58(81.7)

41(77.4)

 

39(83.0)

60(78.0)

 

22(84.62)

77(78.57)

Treatment of GERD

  

0.06

  

0.85

  

0.65

Yes(%)

23(32.4)

26(49.0)

 

18(38.3)

31(40.26)

 

9(34.62)

40(40.82)

No(%)

48(67.6)

27(51.0)

 

29(61.7)

46(59.74)

 

17(65.38)

58(59.18)

Asthma severity

  

0.50

  

0.04

  

0.0002

Mild(%)

10(14.0)

2(3.8)

 

8(17.0)

4(5.2)

 

8(30.77)

4(4.10)

Moderate(%)

21(29.7)

11(20.7)

 

14(29.8)

18(23.4)

 

6(23.08)

26(26.52)

Severe(%)

40(56.3)

40(75.5)

 

25(53.2)

55(71.4)

 

12(46.15)

68(69.38)

FVC, % of predicted(SD)

90.22(18.38)

82.67(19.79)

0.03

94.89(18.67)

82.17(18.13)

0.0003

100.99(19.80)

83.28(17.44)

0.0002

FEV1 , % of predicted(SD)

72.92(20.42)

65.36(21.99)

0.05

80.91(19.57)

62.91(19.54)

<0.0001

88.23(18.83)

64.68(19.18)

<0.0001

FEV1/FVC ratio (SD)

79.93(12.62)

77.63(12.73)

0.32

84.70(10.98)

75.47(12.41)

0.0002

87.41(10.99)

76.65(12.15)

<0.0001